title: Etoposide phosphate hypersensitivity overcome using a desensitisation programme enabling optimal therapy for relapsed Hodgkin lymphoma.
authors: Haematology Department, Fiona Stanley Hospital, Murdoch, Western Australia, Australia.
authors: P
authors: P
authors: Polistena
authors: Pharmacy Department, Fiona Stanley Hospital, Murdoch, Australia.
authors: Q
authors: Q
authors: Tran
authors: Haematology Department, Fiona Stanley Hospital, Murdoch, Western Australia, Australia.|Pathwest Laboratory Medicine, Fiona Stanley Hospital, Murdoch, Australia.
authors: M
authors: M
authors: Cirillo
authors: Pathwest Laboratory Medicine, Fiona Stanley Hospital, Murdoch, Australia.|Department of Clinical Immunology, Fiona Stanley Hospital, Murdoch, Australia.
authors: M
authors: M
authors: O'Sullivan
authors: Haematology Department, Fiona Stanley Hospital, Murdoch, Western Australia, Australia.|Pathwest Laboratory Medicine, Fiona Stanley Hospital, Murdoch, Australia.
authors: D
authors: D
authors: Purtill
mesh_terms: D000328:Adult; D003888:Desensitization, Immunologic; D004342:Drug Hypersensitivity; D005047:Etoposide / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives*; D006689:Hodgkin Disease / Q000188:drug therapy*; D006801:Humans; D008297:Male; D009943:Organophosphorus Compounds / Q000008:administration & dosage / Q000009:adverse effects; D012008:Recurrence
chemical_list: D009943:Organophosphorus Compounds; C061400:etoposide phosphate; D005047:Etoposide